Name | Sonepcizumab |
---|
Description | Sonepcizumab (LT 1009) is a fully humanized anti-S1P monoclonal antibody. Sonepcizumab has the potential for the research of metastatic renal cell carcinoma (mRCC)[1]. |
---|---|
Related Catalog | |
References |
No Any Chemical & Physical Properties |